Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier

NCT02633787 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis
Meningococcal Meningitis
Meningococcal Infections

Interventions

BIOLOGICAL: Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company